Company Encyclopedia
View More
name
NUOBIKAN
02635.HK
Nuobikan Artificial Intelligence Technology (Chengdu) Co., Ltd. designs and develops an industrial application of advanced technologies including AI and digital twins that target areas of transportation, energy, and urban management. The company provides integrated software and hardware solutions adopting comprehensive AI industry models for monitoring, inspection and maintenance purposes. It also offers rail transit for transportation solution business, electricity for energy solution business, and urban management solution business.
527.86 B
02635.HKMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Top 10 HK Stock Losers (12.29)

    MGM CHINA(02282) fell 17.14%, with a trading turnover 631.2 Million HKD, and a year-to-date rose 37.7%. NUOBIKAN(02635) fell 15.11%, with a trading turnover 23.4 Million HKD, and a year-to-date rose 320%. EVEREST MED(01952) fell 14.97%, with a trading turnover 729.9 Million HKD, and a year-to-date fell 21.6%.

    Top Gainers & Losers·
    HK
    02282
    -17.14%
    HK
    02635
    -15.11%
    HK
    01952
    -14.97%
    Top Gainers & Losers·
    HK
    02282
    -17.14%
    HK
    02635
    -15.11%
    HK
    01952
    -14.97%

    Morning Trend | NUOBIKAN consolidates sideways, no obvious catalysts in the medical equipment sector

    NUOBIKAN (2635.HK) maintained a sideways consolidation yesterday, with limited intraday volatility. The MACD golden cross pattern continues horizontally but with weakened momentum. Currently, the medical equipment sector lacks obvious catalysts, and market participants are operating cautiously. NUOBIKAN's stock price has repeatedly tested the 5-day and 10-day moving averages for support, but the upward pressure has not seen a breakthrough, showing a trend of shrinking volume consolidation. From a fundamental analysis perspective, the progress of clinical trials and market promotion of the company's product pipeline are medium to long-term highlights, but there have been no significant breakthroughs or positive news in the short term. The industrial policy front is relatively flat, and market sentiment is heavily wait-and-see. The continuous reduction in trading volume indicates increasing divergence among funds, with major players remaining on the sidelines. In terms of investment advice, short-term attention should be paid to market fluctuations and fund status. If there are new changes in industry policies or significant project progress, it may ignite the enthusiasm of funds for aggressive investment. Otherwise, the sideways pattern will continue, and it is recommended to mainly adopt a wait-and-see approach, with only strategic investors suitable for gradual low-cost buying, while short-term funds should avoid participating in high-volatility operations

    Technical Forecast·
    HK
    02635
    -15.11%
    Technical Forecast·
    HK
    02635
    -15.11%

    News: The lower-priced NUOBIKAN surged more than three times on its first day of listing

    NUOBIKAN Artificial Intelligence Technology (Chengdu) Co., Ltd. saw its stock price soar more than three times on its first day of trading in Hong Kong, opening at HKD 319.8 and closing at HKD 351 at midday. The company issued 3.7866 million shares at a lower limit price of HKD 80 per share, raising a net financing amount of HKD 257 million. Despite the impressive stock performance, the company's financial situation is poor, with accounts receivable and impairment losses continuing to increase, and the average turnover days significantly rising

    BambooWorks·
    HK
    02635
    -15.11%
    BambooWorks·
    HK
    02635
    -15.11%

    "New Shares" NUOBIKAN closed at 351 yuan for half a day, up 338.8% from the listing price

    NUOBIKAN listed on its first day, opening at 319.8 yuan, up 299.8% from the listing price of 80 yuan. The highest/lowest prices were 356.8/310 yuan, closing at 351 yuan, up 338.8% from the listing price of 80 yuan. The half-day trading volume was 784,000 shares, involving 194 million yuan

    AASTOCKS·
    HK
    02635
    -15.11%
    AASTOCKS·
    HK
    02635
    -15.11%

    "New Stocks" NUOBIKAN opened at 319.8 yuan on the first day, a high listing price of 299.8%

    NUOBIKAN's dark market closed at 300.4 yuan yesterday, 275.5% higher than the listing price. Today is the first day of listing, opening at 319.8 yuan, 80 yuan higher, a 299.8% increase, with a trading volume of 639,500 shares during the opening period

    AASTOCKS·
    HK
    02635
    -15.11%
    AASTOCKS·
    HK
    02635
    -15.11%
    © 2025 Longbridge｜Disclaimer